Platelets, traditionally recognised for their role in haemostasis, have emerged as active participants in the aetiology and progression of neurodegenerative disorders through mechanisms that bridge ...

Platelets are increasingly recognised as active participants in tumour progression rather than mere bystanders of haemostasis. Tumour cells express procoagulant factors that trigger platelet ...

Intestinal blooms of Ruminococcus gnavus, which produce a novel lipoglycan toxin, are linked to a distinct lupus nephritis ...

Platelets are small, anucleate blood cells that play an essential role in hemostasis. Their primary task is to recognize vascular injury, become activated, and aggregate via their surface receptor ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...

Randomized trial from China suggests better functional independence ...

Pharmacological Approaches Targeting Neutrophilic Inflammation: Volume II.Neutrophils (or polymorphonuclear leukocytes, ...

Blood clotting depends on speed, force, and timing. Platelets have to stay quiet while circulating through the body, then ...

Scientists at the University of Leeds have used cryo-electron microscopy to reveal how platelet myosin stays inactive until needed for blood clotting. The study identified structural 'off-switch' ...

Thrombocytopenia is an atypically low platelet count. Acquired thrombocytopenia is caused by conditions that develop throughout your life instead of genes inherited from birth. Acquired ...